GMAB:CPH
Genmab A/S
DKKÂ 2,092.00
arrow_upward
+0.43%(+9.00) 1D
Sep 11, 5:00:00 PM GMT+2 · DKK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
DKKÂ 2,082.00
High
DKKÂ 2,104.00
Low
DKKÂ 2,066.00
Mkt. cap
130.69B
Avg. vol.
111.21K
Volume
0.00
52-wk high
DKKÂ 2,257.00
52-wk low
DKKÂ 1,512.00
Shares outstanding
62.41M
No. of employees
3K
Open
DKKÂ 2,082.00
High
DKKÂ 2,104.00
Low
DKKÂ 2,066.00
Mkt. cap
130.69B
Avg. vol.
111.21K
Volume
0.00
52-wk high
DKKÂ 2,257.00
52-wk low
DKKÂ 1,512.00
Shares outstanding
62.41M
No. of employees
3K
News stories
From web sources and news partners
ad-hoc-news.de
·
2 days ago
Genmab stock gains as capital increase and updated Articles of Association support growth plans
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S
CEOJan G. J. van de Winkel
Employees3.12K
Founded1999
Headquarters-
SectorBiotechnology
Websitegenmab.com